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Summary
Objective: Because articular cartilage has limited ability to repair itself, treatment of (osteo)chondral lesions remains a clinical challenge. We
aimed to evaluate how well a tissue-engineered cartilage-like implant, derived from chondrocytes cultured in a novel patented, scaffold-free
bioreactor system, would perform in minipig knees with chondral, superficial osteochondral, and full-thickness articular defects.
Design: For in vitro implant preparation, we used full-thickness porcine articular cartilage and digested chondrocytes. Bioreactors were
seeded with 20×106 cells and incubated for 3 weeks. Subsequent to culture, tissue cartilage-like implants were divided for assessment of
viability, formaldehyde-fixed and processed by standard histological methods. Some samples were also prepared for electron microscopy
(TEM). Proteoglycans and collagens were identified and quantified by SDS-PAGE gels. For in vivo studies in adult minipigs, medial
parapatellar arthrotomy was performed unilaterally. Three types of defects were created mechanically in the patellar groove of the femoral
condyle. Tissue-engineered cartilage-like implants were placed using press-fit fixation, without supplementary fixation devices. Control
defects were not grafted. Animals could bear full weight with an unlimited range of motion. At 4 and 24 weeks postsurgery, explanted knees
were assessed using the modified ICRS classification for cartilage repair.
Results: After 3-4 weeks of bioreactor incubation, cultured chondrocytes developed a 700-m- to 1-mm-thick cartilage-like tissue. Cell
density was similar to that of fetal cartilage, and cells stained strongly for Alcian blue and safranin O. The percentage of viable cells remained
nearly constant (∼90%). Collagen content was similar to that of articular cartilage, as shown by SDS-PAGE. At explantation, the gross
morphological appearance of grafted defects appeared like normal cartilage, whereas controls showed irregular fibrous tissue covering the
defect. Improved histologic appearance was maintained for 6 months postoperatively. Although defects were not always perfectly level upon
implantation at explanation the implant level matched native cartilage levels with no tissue hypertrophy. Once in place, implants remodelled
to tissues with decreased cell density and a columnar organization.
Conclusions: Repair of cartilage defects with a tissue-engineered implant yielded a consistent gross cartilage repair with a matrix
predominantly composed of type II collagen up to 6 months after implantation. This initial result holds promise for the use of this unique
bioreactor/tissue-engineered implant in humans. © 2001 OsteoArthritis Research Society International
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The response of articular cartilage to injury does not
consistently restore a durable weight-bearing surface for
motion, as many studies have shown1–8. In articular carti-
lage defects that penetrate the subchondral bone, mesen-
chymal cells migrate into the damaged zone and
reorganize into a cartilaginous tissue that degenerates at a
later stage9. Purely chondral defects (CD) do not heal
spontaneously10–12. Chondrocytes respond to injury by
proliferating and increasing the synthesis of matrix mol-
ecules near the injury, but the newly produced extracellular
matrix and proliferating cells do not completely repair the
tissue defect, and soon after injury the increased prolifera-
tive and synthetic activity ceases13.
Articular cartilage repair remains a clinical and scientific
challenge. Currently, prosthetic joint replacement is theS6usual clinical approach for treating severe and extended
degeneration of the cartilage, but its complications include
infection and loosening of the components14. Biological
resurfacing is an alternative technology that could result in
successful long-term regeneration. Some of the strategies
being investigated include chondrogenic cell transplan-
tation, periosteal and perichondrial tissue grafting, sub-
chondral drilling, osteochondral auto/allografting, and cell
recruitment using various growth factors10,15–28.
Technical difficulties in fixing tissue grafts or isolated cell
suspension into the cartilage defects have led to exper-
imentation with fibrin glue, sutures, resorbable pins, and
periosteal patches. Another potential solution is to
encapsulate the repair cells within a biodegradable
scaffold16,29–31. The scaffold provides a three-dimensional
structure for in vitro chondrocyte proliferation and for con-
trolling the shape of the regenerated cartilage for implan-
tation. However, the production of such scaffolds is a
complex procedure involving many biocompatibility issues.
None of the methods in clinical use is totally satisfactory32,
and there is a need to develop alternative technologies for
the repair of articular cartilage lesions.
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the engineering of articular cartilage-like tissue should start
from small needle-biopsy specimens. Cells are then
required to be expanded in vitro to a sufficient number of
cells to be able to generate a construct with a certain
mechanical stability. Accordingly, the novel approach we
have chosen is based on the culturing of chondrocytes
within a bioreactor without using a scaffold33. The culture
within the bioreactor can support high seeding density and
permits us to maintain within that closed environment the
matrix products that are synthesized by the chondrocytes.
The purpose of the present study was to investigate the
production of a cartilage-like implant (DeNovo, Sulzer Bio-
logics, Winterthur, Switzerland) within the bioreactor sys-
tem and to study how the tissue-engineered implant would
be affected by short-term implantation.Methods
CELL CULTURE AND CONSTRUCT PREPARATION
Articular cartilage slices were harvested aseptically from
the proximal humerus of butchered adult pigs within 8 h of
slaughter and cut into small pieces. Chondrocytes were
isolated overnight by enzymatic digestion (pronase and col-
lagenase II, Boehringer Mannheim GmBH, Germany). The
liberated cells were passed through a 100-m Nylon Cell
Strainer filter (Becton Dickinson, New Jersey, U.S.A.) to
single-cell suspension and resuspended in Dulbecco’s
modified Eagle medium containing 10% fetal bovine serum,
4.5 g/l glucose, HEPES buffer, ascorbic acid, penicillin, and
streptomycin. An aliquot of the cell suspension was exposed
to trypan blue, and the number of viable and dead cells was
determined. After several passages, the cells were trans-
ferred into bioreactors (EU-Patent Nr. 922093, 1998) at a
seeding density of 20×106 per 0.4 to 0.5 ml. The bioreactors
were closed with two Cellulose Ester membranes MWCO:
100,000 daltons (Spectrum, California, U.S.A.), and the
culture medium (10 ml) that surrounded the bioreactor
chamber was changed three times per week. The culture
conditions were held constant at 37°C in an atmosphere of
5% CO2 and 90% humidity. After 3 weeks, the bioreactors
were opened and the constructs were sampled.IN VITRO IMPLANT EVALUATION
Within the implant, live and dead cells were simul-
taneously viewed in situ using a fluorescent double-stain
protocol followed by confocal microscopy (LSM 410, Zeiss,
Germany). Calcein AM (Molecular Probes, Oregon,
U.S.A.), a fluorescein derivative that is metabolized by
nonspecific esterases present in viable cells, was used to
stain live cells. Use of ethidium homodimer-1 (Molecular
Probes, Oregon, U.S.A.), a nucleic acid stain which is
excluded by intact cell membranes, enabled the nuclei of
dead cells to be visualized34.
The implants were also fixed in 4% formaldehyde (24 h)
and processed by standard histological methods (safranin
O, Masson’s trichrome and Alcian blue). For electron
microscopy, the Richards/Kaab protocol was used to
prepare the samples35. Proteoglycans and collagens were
identified and quantified by SDS-PAGE gels36,37.SURGICAL PROCEDURE
Twenty-two skeletally mature Yucatan minipigs (26–
60 kg) were used for the implantation experiments(Elleguard, Dalmose, Denmark). Six of these animals were
operated on in a pilot phase to study the various fixation
alternatives (results are not reported in the present work).
All procedures were performed under the permission of the
Swiss government animal rights protection authorities (BE/
13/97). Under general anaesthesia (Halothan®) and anti-
biotic prophylaxis with oxytetracycline LA i.m., the left knee
joint was opened by a medial parapatellar incision and the
patella was dislocated laterally. CDs, superficial osteo-
chondral defects (OCSs), and full-thickness articular
defects (FTs) were created mechanically in the patellar
groove of the femoral condyle. Eight animals per obser-
vation period were used, and six to eight defects per joint
were created. The defects were either filled with the
cartilage-like implant cartilage or left empty (control). The
implants were placed using press-fit fixation. For that
purpose, a special instrument was developed. The instru-
ment allowed us to create cartilage defects of 4.0 mm
diameter and cut corresponding cartilage implants to
4.1 mm (press-fit 0.1 mm). The implants were installed so
as to form (as precisely as possible) a level surface with the
surrounding cartilage. The knee joint was sutured in layers
and bandaged. All the animals were returned to cage
activity following surgery without immobilization of the oper-
ated limb and to unrestricted free-range outdoor activities
3 days postsurgery.EXPLANT ASSESSMENT
The minipigs were euthanized at 4 and 24 weeks after
the operation by a lethal dose of potassium chloride infused
during anaesthesia. The entire knee was dissected,
examined macroscopically, and photographed. The biologi-
cal acceptability of the repair was determined following
gross examination in accordance with the International
Cartilage Repair Society (ICRS) classification38. Biologi-
cally acceptable repairs were defined as a smooth, firm
repair tissue that filled the defect and appeared attached to
the surrounding cartilage. The distal part of the femur was
then fixed with 4% buffered formalin for 96 h. Each speci-
men was decalcified in a solution of 0.5 M EDTA containing
0.1 M -amino-n-caproic acid and 0.005 M benzamidine for
2–3 weeks, then embedded in paraffin and sectioned
perpendicularly (8-m thickness) through the centre of the
defect and mounted onto microscopic slides (Superfrost
Colour. Menzel-Gla¨ser, Germany) treated with a ratio of 1:1
egg-white and glycerol (Inselapoteke, Bern, Switzerland).
Each section was stained with haematoxylin and eosin,
toluidine blue O, Masson’s trichome, Alcian blue, and
safranin O—fast green39 and observed under light
microscopy (Leica Leitz, Germany) according to a modified
O’Driscoll, Keeley and Salter histological grading scale
(Table I). Theoretically, perfect healing of a defect was
characterized by 32 points in CD/OCS defects (10 par-
ameters) and 34 points in FT defects (11 parameters)
(Table I)12,28,40–42. Two independent histopathologists ana-
lysed the specimens. In the present study, scores were
determined using only histological sections taken from the
middle of the defect, where repair takes place most slowly.ResultsEVALUATION OF CULTURED CHONDROCYTES IN VITRO
After 3 weeks of bioreactor incubation, chondrocytes
developed into a cartilage-like tissue 700 m to 1 mm thick.
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cell density was similar to that of fetal cartilage and stained
strongly for Alcian blue and safranin O (Fig. 1A-B). The
percentage of viable cells remained nearly constant at
about 90%, as assessed with confocal microscopy
(Fig. 1C). Collagen content was similar to that of articular
cartilage, as shown by SDS-PAGE (Fig. 2). Scanning
electron microscopy revealed the formation of a chondron-
units consistent with the native chondrocyte arrangement
(Fig. 1D).MACROSCOPIC OBSERVATIONS OF CARTILAGE DEFECTS
At no time following implantation were signs of arthrosis
such as osteophytes, cartilage erosion, or synovial
proliferation observed in any operated knee.
As early as 4 weeks after implantation, the defects
repaired by the implant were noticeably smoother than the
untreated defects. The treated defect sites were more
yellow and less translucent than the surrounding cartilage
(Fig. 3). The junction between the two was not clearly
visible. The general appearance of the control defect sites
showed varying degrees of cartilage resurfacing of the
articular defects with repair tissue. All were mainly white
and tan.
At 24 weeks, the colour in the treated defects was similar
to that of normal adjacent cartilage. The colour of the
untreated defects varied from white to tan-purple, and
the texture ranged from irregular to smooth. Results of
the implant macroscopic score are detailed in Table II.
All defects treated with the tissue-engineered implant
exhibited a score higher than 8 on the ICRS classifi-
cation, which corresponds to a normal or nearly normal
appearance.Table I
Histological Grading Scale
Category Points
I: Tissue morphology
Mostly hyaline cartilage 3
Mostly fibrocartilage 2
Mostly non-cartilage 1
Non-cartilage only 0
II: Matrix staining (safranin-O)
Normal or nearly normal 3
Moderate 2
Slight 1
None 0
III: Structural integrity
Normal 4
Beginning of a columnar organization 3
No organization 2
Cysts or disruptions 1
Severe disintegration 0
IV: Chondrocyte clustering
No clusters 2
<25% of the cells 1
25–100% of the cells 0
V: Formation of tidemark
Complete 4
76–90% 3
50–75% 2
25–49% 1
<25% 0
VI: Subchondral bone formation*
Good 2
Slight 1
No formation 0
VII: Architecture of the surface
Normal 3
Slight fibrillation or irregularity 2
Moderate fibrillation or irregularity 1
Severe fibrillation or disruption 0
VIII: Filling of the defect**
91–110% 4
76–90% 3
51–75% 2
26–50% 1
<25% 0
IX: Lateral integration
Bonded at both ends of graft 2
Bonded at one end/partially at both sides 1
Not bonded 0
X: Basal integration
91–100% 3
70–90% 2
50–70% 1
<50% 0
XI: Inflammation
No inflammation 4
Slight inflammation 2
Strong inflammation 0
Total (max. 34 points)
*Category VI is not used in evaluating chondral and OCS
defects.
**Category VII assigns a 3 to ‘‘111–125’’ (not shown) because
such overfilling is considered a less than optimal result.HISTOLOGIC SCORING OF THE REPAIR TISSUE
The implanted grafts enhanced cartilage repair at all time
points evaluated in this study (Table III): the composite
histologic scores at 4 and 24 weeks were 19.1 and
20.5 points respectively for treated chondral defects com-
pared with 11.4 and 12.1 points for the corresponding
controls. For treated OCS defects, the scores at 4 and 24
weeks were 22.2 and 20.6 points compared with 11.7 and
12.3 points for the corresponding controls. FT defects had
similar results: 21.6 and 23.2 points for implanted defects
4 weeks and 24 weeks postoperatively, respectively, and
14.9 and 16.8 for corresponding controls. Untreated
defects rapidly filled with disorganized fibrocartilage that
did not restore a continuous articular surface with the
surrounding hyalin cartilage (Fig. 4A). In contrast, the
defects repaired using implants were filled with a tissue
of high cell density. At higher magnification, the cells
resembled well-differentiated chondrocytes and were sur-
rounded by a metachromatic matrix (Fig. 4B). Gaps or
discontinuities between the repair tissue and the adjacent
cartilage were observed in only a few cases. In others, the
lateral integration was perfect. Areas in the native cartilage
adjacent to the defect were hypocellular. No defects had
clefts or fissures. A certain implant reorganization into a
columnar pattern could also be seen (Fig. 4D), and in some
cases a lateral regeneration from the defect edges was
also noted (Fig. 4C).
At 24 weeks postimplantation, the hyalin character of the
implants was maintained in both CDs and OCSs (Fig. 5A).
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still higher than that of native cartilage (Fig. 5B). No signs of
surface fibrillation or fissure were seen. Safranin O-fast
green staining was evident throughout the repair tissue, but
its intensity was slightly reduced compared with that of the
adjacent cartilage. The thickness of the repair cartilage was
90–100% that of the normal cartilage. However, tissue
hypertrophy was not seen. A complete tidemark could not
be seen. In some FT defects, enchondral bone formation
was observed (Fig. 5C) and in some, an inflammatory
response was observed. This was rarely the case with OCS
or CD repairs. Implant loosening had occurred in 55% of
the CD, 20% of the OCS, and 8% of the FT sites. Of theselatter 8%, only mild fibrillation of the surface was apparent,
mainly because of an infiltration of the surface by inflam-
matory cells. The control defects had a higher percentage
of surface fibrillation, with no inflammatory infiltration of the
surface. The thickness of the repair cartilage was 75% that
of the normal adjacent cartilage in the case of CD and OCS
repairs.A B
C D
Fig. 1. (A) Macroscopic appearance of DeNovo after removal from the bioreactor. (B) Light microscopic appearance of DeNovo after removal
from the bioreactor. Cells are round and are surrounded by a metachromatic matrix. Cellular organization is similar to that of fetal cartilage.
Alcian blue, 10×10. (C) Confocal microscopy view of DeNovo after removal from the bioreactor. Viable cells are marked in green by calcein
AM (Molecular Probes, Oregon, U.S.A.), dead cells are marked in red by Ethidium homodimer-1 (Molecular Probes, U.S.A.). Ninety per cent
of the DeNovo construct is made from viable cells. (D) Scanning electron microscopic view of the implant after removal from the bioreactor
(Courtesy of Dr Ka¨a¨b).0,0
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Fig. 2. Percentage of collagen content of DeNovo implants after 4 weeks in the bioreactor (SDS-PAGE gel analysis).Discussion
In monolayer culture, the number of chondrocytes
increases greater than 100 times. During this proliferation
S10 P. Mainil-Varlet et al.: Articular cartilage repair using a tissue-engineered cartilage-like implantFig. 3. Macroscopic appearance of an operated knee at explan-
tation after 4 weeks of follow-up. Control defects are marked (*)
and are primarily white and tan. The implant sites were more
yellow and less translucent than the surrounding cartilage.Table III
Scores according to the Modified Histological Grading Scale
Defect type (FU) Category (*) Total score Φ
I II III IV V VI VII VIII IX X XI
Chondral
DeNovo (4 weeks) 2.7 2.7 1.9 0.3 0.7 — 2.3 3.2 1.0 1.0 3.3 19.1±1.6
Control (4 weeks) 1.5 0 0.5 2 0 — 2.0 1.4 0 0 4 11.4±0.8
DeNovo (24 weeks) 3.0 3.0 2.0 1.6 0.9 — 2.4 3.8 1.0 0 2.8 20.5±1.4
Control (24 weeks) 1.2 0 0.6 2 0 — 1.4 2.9 0 0 4 12.1±1.3
OCS
DeNovo (4 weeks) 3.0 2.7 2.3 1.3 0.8 — 2.2 4.0 0.9 1.7 3.3 22.2±1.9
Control (4 weeks) 1.1 0 0.8 2 0 — 2.0 1.8 0 0 4 11.7±1.0
DeNovo (24 weeks) 3.0 3.0 2.7 1.0 0.9 — 2.7 3.7 0.7 0 2.2 20.6±2.3
Control (24 weeks) 1.2 0 0.9 2 0 — 1.3 2.9 0 0 4 12.3±1.4
FT
DeNovo (4 weeks) 2.8 2.2 1.9 1.0 0.9 0.5 2.6 3.6 1.1 2.3 2.7 21.6±2.3
Control (4 weeks) 2.2 0 1.2 2 0 0.5 2.0 3.0 0 0 4 14.9±0.9
DeNovo (24 weeks) 3.0 2.9 2.8 1.4 0.7 1.2 2.3 3.9 1.2 1.9 1.9 23.2±2.1
Control (24 weeks) 2.3 0 1.5 2 0 1.9 1.2 3.9 0 0 4 16.8±1.4
(*) Values are given as the average score (in points) for each category, as assessed by two different investigators.
Φ values are given as the average and standard deviation.
FU: time of follow-up; OCS: osteochondral superficial defect type; FT: full thickness defect type.Table II
Scores according to ICRS Assessment Macroscopic Scale
Defect Type 4 weeks 24 weeks
Chondral
Implant 9±2 8±2
Control 7±1 6±1
OCS
Implant 9±2 10±1
Control 8±1 8±1
FT
Implant 11±2 11±2
Control 7±2 6±3period, the chondrocytes shift from the synthesis of
collagen (type II) to collagen types I and III and exhibit
a fibroblast cell-like phenotype43–44. Dedifferentiated
chondrocytes placed in a three-dimensional scaffold will
recover and redifferentiate45–50, and each scaffold’s physi-
cal and chemical characteristics determine whether the
seeded cells will grow and maintain their phenotype and
extracellular matrix production. These characteristics
include the scaffold’s texture, porosity (size, structure,
distribution), hydrophilicity, and surface free energy30,51.These factors are strongly influenced by the quality of the
polymer, its degradation rate, and the technique used for
scaffold preparation. Observations on the most widely used
polymers have often evidenced the presence of a second,
delayed tissue response in addition to the initial reaction
following surgery for the implantation procedure. Such a
response, sometimes years after implantation52,53, is nor-
mally associated with the beginning of chemical and mech-
anical degradation of the material and involves the
presence of phagocytic cells associated with the material
resorption process. The use of certain natural polymers is
of interest in this regard54. It is therefore rather complicated
to produce an ideal scaffold that will allow chondrocytes to
keep their phenotype and allow a perfect matrix assembly.
Furthermore, the implantation of a foreign material within
patients necessitates informed consent and permission
from the regulatory authorities often a long, expensive, and
complicated process.
To solve these problems, we prepared the self-contained
three-dimensional cell culture system described herein, a
system that enables chondrocytic cells to maintain/restore
their functional phenotype. We have developed an auto-
logous cartilage-like implant starting from a small biopsy.
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Fig. 4. (A) Light microscopic appearance of control defect, 24 weeks postsurgery. The defect is filled with fibrocartilage. (B) Light microscopic
appearance of an FT defect treated with the implant, 4 weeks postsurgery. The cells resemble well-differentiated chondrocytes and are
surrounded by a metachromatic matrix. Native cartilage (*), tissue-engineered cartilage (+). (C) Light microscopic appearance of the implant,
4 weeks post-implantation with lateral regeneration tentative from the defect’s edges. (D) Light microscopic appearance of the implant,
4 weeks post-implantation. Maintenance of the hyalin cartilage characteristic and beginning of a columnar organization.The culturing of chondrocytes in our bioreactor allows us to
bypass some methodological limitations of the techniques
currently in clinical use, including the shortage of donor
tissue and donor site morbidity needed for autografts, the
risks of immune rejection and pathogen transfer with allo-
grafts, the delayed inflammatory response observed with
most resorbable scaffolds, and the limited service life and
toxicity of artificial prostheses. The implantation of a more
‘finished’ cartilage implant avoids the use of a periosteal
flap, a time-consuming technique, whose results depend
on the surgeon’s manual dexterity and which has well-
described detrimental effects on the adjacent cartilage55,56.
In addition, a more ‘finished’ implant protects chondrocytes
surrounded by their newly synthesized matrix from mech-
anical injuries and from influences of interfering cells in
vivo. However, the production of such a tissue-engineered
implant requires more in vitro time, which is certainly a
limiting factor.
Our bioreactor system has the great advantage of con-
taining the newly synthesized extracellular matrix products
within a confined space. The extracellular matrix produced
appears to provide an optimal three-dimensional structure
for the chondrocytes’ survival, proliferation in a controlledmanner by forming chondron, and further synthesis of
cartilage-specific components. It is likely that the matrix
produced by the tissue-engineered implant permits
almost free flux and diffusion of chemical signals, growth
factors, and cytokines and permits the formation of new
cartilage-like matrix to reinforce the implants.
The grading scale used in our study allowed for an
objective analysis of the healing of the defects. The repair
tissue appeared to be predominantly hyalin-like, and some
cells situated at the base of the implant formed clusters as
early as 4 weeks after implantation. Cluster formation of
chondrocytes is a common finding in osteoarthritic cartilage
and is a sign of increased mitotic activity. In all histologic
grading scales, chondrocyte clustering is regarded as a
negative finding, thus lowering the total grade of the
sections examined. The cluster formation found in our case
should be regarded as a newly organized repair tissue and
not as a degenerative phenomenon. Most of the clusters
were seen in the base of the implant, probably resulting
from mechanical stimulation, i.e., the base of the implant
being constantly pushed against the bone/cartilage base.
The depth of a given lesion is an important factor in
determining which defects healed. CDs had a much higher
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Fig. 5. (A) Light microscopic appearance of an FT defect treated with the implant, 24 weeks postsurgery. Native cartilage (*),
tissue-engineered cartilage (+). (B) Light microscopic appearance of the implant, 24 weeks post-implantation. Decrease in cellularity,
however still higher than native tissue. Maintenance of hyalin character. (C) Light microscopic appearance of an FT defect treated with a the
implant, 24 weeks postsurgery. Native cartilage (*), tissue-engineered cartilage (+).rate of implant loosening than OCS or FT defects. We
purposely did not use an additional fixation device to avoid
further biocompatibility issues. (We plan to address the
fixation problems in a different project using a model more
closely resembling human tissue.) The high incidence of
implant loosening in CDs may be explained by the fact that
we did not immobilize the limbs postsurgery55. The ten-
dency of chondrocytes to regenerate from the lateral mar-
gin may have helped to expel a weakly anchored implant.
Critical for integration of the graft is the rapid formation of a
tight contact between the graft and the surrounding tissue,
which requires infiltration of fibrin and merging of the new
cartilage matrix with the surrounding natural matrix.
Although the morphological features of the repair
cartilage and the composition of the matrix in the treated
defects were superior to those in the untreated defects, the
integration of the repair tissue with the normal adjacentcartilage was still not optimal. Other investigators have
commented that the lack of integration of repair tissue with
adjacent cartilage is unrelated to the method of treatment
or the size of the defects19,25,57–64. Integration at the
margins is a difficult problem to overcome because
chondrocytes in normal cartilage are not involved in the
repair and cannot migrate9,65. The ultimate success of
repair cartilage may require its integration with surrounding
articular cartilage to maintain biomechanical integrity.
Some investigators have reported that better integration at
the interface is associated with enzymatic treatment of the
defect at the time of operation9,62. The treatment of the
edges of the exposed cartilage may enhance cellular
adhesion by removing matrix factors that inhibit such ad-
hesion as well as by enhancing integration of the
matrix10,66. The lower rate of loosening and better lateral
integration in the case of OCS and osteochondral defects
Osteoarthritis and Cartilage Vol. 9 Suppl. A S13can be explained by the fact that the defect walls become
coated with endogenous fibrin after the implant is in place.
Since the thickness of minipig articular cartilage, like that
of humans, varies considerably at different anatomical
sites, we used site matching to ensure that each graft had
similar curvature to the surroundings. Although the grafts
were not perfectly at the same level as the surrounding
cartilage at surgical implantation, they were found to be at
the same level cartilage at explantation. No tissue hyper-
trophy was observed (an earlier study67 had reported that
13% of the cases of patients who had received a periosteal
flap and chondrocyte application did exhibit hypertrophy).
The tissue-engineered grafts we studied had matured in
vivo, allowing the graft to be at the same level as the
surrounding cartilage as early as 4 weeks postsurgery. The
maturation process also resulted in a columnar organiz-
ation of the chondrocytes and a decrease of cellularity. The
thickness of the articular cartilage is approximately 0.7 mm
for porcine (minipig) cartilage compared with 3 mm for
human cartilage. This important difference will affect the
size of the implant that will have to be inserted into a human
joint and therefore increase the time for its in vitro prep-
aration. The fact that the tissue-engineered implants have
been shown to mature in vivo could thus be of considerable
advantage to surgeons and patients.
In 15% of the grafts we examined, new subchondral
bone was formed in place of the original bone. Bone
trabecules developed in the deep zone of the graft, enclos-
ing small residual chondrocyte islands. The inconsistent
restoration of the subchondral bone raises concerns about
the immunologic acceptance by the host of an allogenic
implant. The host’s immune response to the allogenic
implant may have affected the repair process adversely in
the poorer specimens we examined. This supposition is
supported by results from several previous studies23,68.
Efforts to enhance restoration of the subchondral bone may
play an important role in future efforts to repair FT articular
cartilage lesions in humans.Conclusions
The bioreactor system described in the present work can
provide useful, complementary information regarding the
process of cartilage matrix regeneration starting from iso-
lated chondrocytes (e.g., mechanical stimulation, effects of
cell density, cell source, and specific growth factors). In the
current study, repair of cartilage defects with the tissue-
engineered implant consistently yielded cartilage gross
repair and matrix composed of predominantly Type II
collagen for 6 months after implantation. Further investi-
gation may yield a method of cartilage repair superior to the
techniques now used. Although the findings of this short-
term study in minipigs provided evidence of a superior
repair with use of the tissue-engineered implant, further
investigations are needed to clarify the long-term behaviour
of such cartilage-like implants. Future experiments should
especially address autologous transplantation. Studies
further characterizing the mechanism of cartilage-like
implants formation are currently underway.Acknowledgments
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